Photodynamic Therapy and Topical Aminolevulinic Acid: An Overview

American Journal of Clinical Dermatology

Volumn 4, Issue 10, 2003, Pages 699-708

  Gupta, Aditya K ^a,b,c   Ryder, Jennifer E ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MEDIPROBE RESEARCH INC   (Canada)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; FREE RADICAL; PROTOPORPHYRIN; REACTIVE OXYGEN METABOLITE;

ACNE VULGARIS; ACTINIC KERATOSIS; ADULT; AGED; ALOPECIA AREATA; BASAL CELL CARCINOMA; BOWEN DISEASE; CLINICAL TRIAL; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MYCOSIS FUNGOIDES; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PSORIASIS; REVIEW; SQUAMOUS CELL CARCINOMA; VERRUCA VULGARIS; WART VIRUS;

ADMINISTRATION, TOPICAL; AMINOLEVULINIC ACID; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN DISEASES;

EID: 0242635695     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200304100-00004     Document Type: Review

References (62)

1. Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol 2000; 42: 389-413
2. Ormrod D, Jarvis B. Topical aminolevulinic acid HCl photodynamic therapy. Am J Clin Dermatol 2000; 1: 133-9
3. DUSA Pharmaceuticals. Levulan® Kerastick® (aminolevulinic acid HCl) for Topical Solution, 20% [package insert]. DUSA Pharmaceuticals Inc., Wilmington (MA); 2000
4. Morton CA, Brown SB, Collins S, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002; 146: 552-67
5. Bissonnette R, Lui H. Current status of photodynamic therapy in dermatology. Dermatol Clin 1997; 15: 507-19
6. Peng Q, Warloe T, Berg K, et al. 5-aminolevulinic acid-based photodynamic therapy: clinical research and future challenges. Cancer 1997; 79: 2282-308
7. Szeimies RM, Calzavara-Pinton PG, Karrer S, et al. Topical photodynamic therapy in dermatology. J Photochem Photobiol B 1996; 36: 213-9
8. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 1992; 14: 275-92
9. Lui H, Anderson RR. Photodynamic therapy in dermatology: recent developments. Dermatol Clin 1993; 11: 1-13
10. Fritsch C, Goerz G, Ruzicka T. Photodynamic therapy in dermatology. Arch Dermatol 1998; 134: 207-14
11. Food and Drug Administration Center for Drug Evaluation and Research. Dermatologic and Ophthalmic Drugs Advisory Committee open session: NDA 20-965 Levulan® Kerastick® for topical solution. Food and Drug Administration Center for Drug Evaluation and Research 1999
12. Jeffes EW, McCullough JL, Weinstein GD, et al. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid: a pilot dose-ranging study. Arch Dermatol 1997; 133: 727-32
13. Fink-Puches R, Hofer A, Smolle J, et al. Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light. J Photochem Photobiol B 1997; 41: 145-51
14. Szeimies RM, Karrer S, Sauerwald A, et al. Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. Dermatology 1996; 192: 246-51
15. Jeffes EW, McCullough JL, Weinstein GD, et al. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J Am Acad Dermatol 2001; 45: 96-104
16. Kurwa HA, Yong-Gee SA, Seed PT, et al. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol 1999; 41 (3 Pt 1): 414-8
17. Szeimies RM, Karrer S, Radakovic-Fijan S, et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 2002; 47: 258-62
18. Morton CA, Whitehurst C, McColl JH, et al. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Arch Dermatol 2001; 137: 319-24
19. Svanberg K, Andersson T, Killander D, et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical δ-amino levulinic acid sensitization and laser irradiation. Br J Dermatol 1994; 130: 743-51
20. Guillen C, Sanmartin O, Escudero A, et al. Photodynamic therapy for in situ squamous cell carcinoma on chronic radiation dermatitis after photosensitization with 5-aminolaevulinic acid. J Eur Acad Dermatol Venereol 2000; 14: 298-300
21. Morton CA, Whitehurst C, Moseley H, et al. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol 1996; 135: 766-71
22. Salim A, Morton CA. Comparison of photodynamic therapy with topical 5-fluorouracil in Bowens' disease [abstract]. Br J Dermatol 2000; 143 Suppl. 57: 112-4
23. Morton CA, Whitehurst C, Moore JV, et al. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Br J Dermatol 2000; 143: 767-72
24. Stables GI, Stringer MR, Robinson DJ, et al. Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol 1997; 136: 957-60
25. Soler AM, Angell-Petersen E, Warloe T, et al. Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources. Photochem Photobiol 2000; 71: 724-9
26. Wang I, Bendsoe N, Klinteberg CAF, et al. Photodynamic therapy vs cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 2001; 144: 832-40
27. Haller JC, Cairnduff F, Slack G, et al. Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy. Br J Dermatol 2000; 143: 1270-4
28. Morton CA, Burden AD. Treatment of multiple scalp basal cell carcinomas by photodynamic therapy. Clin Exp Dermatol 2001; 26: 33-6
29. Fink-Puches R, Wolf P, Kerl H. Photodynamic therapy of superficial basal cell carcinoma by instillation of aminolevulinic acid and irradiation with visible light. Arch Dermatol 1997; 133: 1494-5
30. Cairnduff F, Stringer MR, Hudson EJ, et al. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br J Cancer 1994; 69: 605-8
31. Dijkstra AT, Majoie IM, van Dongen JW, et al. Photodynamic therapy with violet light and topical δ-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma. J Eur Acad Dermatol Venereol 2001; 15: 550-4
32. Soler AM, Warloe T, Tausjo J, et al. Photodynamic therapy of residual or recurrent basal cell carcinoma after radiotherpay using topical 5-aminolevulinic acid or methylester aminolevulinic acid. Acta Oncol 2000; 39: 605-9
33. Roberts DJH, Cairnduff F. Photodynamic therapy of primary skin cancer: a review. Br J Plast Surg 1995; 48: 360-70
34. Thissen MRTM, Schroeter CA, Neumann HAM. Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol 2000; 142: 338-9
35. Morton CA, MacKie RM, Whitehurst C, et al. Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. Arch Dermatol 1998; 134: 248-9
36. Orenstein A, Haik J, Tamir J, et al. Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinc acid topical application. Dermatol Surg 2000; 26: 765-70
37. Wolf P, Fink-Puches R, Cerroni L, et al. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. J Am Acad Dermatol 1994; 31: 678-80
38. Kurwa HA, Barlow RJ, Neill S. Single-episode photodynamic therapy and vulval intraepithelial neoplasia type III resistant to conventional therapy. Br J Dermatol 2000; 143: 1040-2
39. Fehr MK, Hornung R, Degen A, et al. Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Lasers Surg Med 2002; 30: 273-9
40. Hillemanns P, Untch M, Dannecker C, et al. Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid. Int J Cancer 2000; 85: 649-53
41. Stables GI, Stringer MR, Robinson DJ, et al. Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol 1999; 140: 514-7
42. Hongcharu W, Taylor CR, Chang Y, et al. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000; 115: 183-92
43. Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer. Br J Dermatol 2002; 146: 178-88
44. Itoh Y, Ninomiya Y, Tajima S, et al. Photodynamic therapy of acne vulgaris with topical 5-aminolevulinic acid. Arch Dermatol 2000; 136: 1093-5
45. Lee WS, Shalita AR, Poh-Fitzpatrick MB. Comparative studies of porphyrin production in Propionibacterium acnes and Propionibacterium granulosum. J Bacteriol 1978; 133: 811-5
46. Cunliffe WJ, Goulden V. Phototherapy and acne vulgaris. Br J Dermatol 2000; 142: 855-6
47. Itoh Y, Ninomiya Y, Tajima S, et al. Photodynamic therapy of acne vulgaris with topical δ-aminolaevulinic acid and incoherent light in Japanese patients. Br J Dermatol 2001; 144: 575-9
48. Fabbrocini G, Costanzo MPD, Riccardo AM, et al. Photodynamic therapy with topical δ-aminolaevulinic acid for the treatment of plantar warts. J Photochem Photobiol B 2001; 61: 30-4
49. Karrer S, Szeimies RM, Abels C, et al. Epidermodysplasia verruciformis treated using topical 5-aminolaevulinic acid photodynamic therapy. Br J Dermatol 1999; 140: 935-8
50. Stender I-M, Wulf HC. Treatment of recalcitrant verrucae by photodynamic therapy with topical application of δ-aminolaevulinic acid. Clin Exp Dermatol 1996; 21: 388-96
51. Stender I-M, Lock-Andersen J, Wulf HC. Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5-aminolaevulinic acid: a pilot study. Clin Exp Dermatol 1999; 24: 154-9
52. Stender IM, Na R, Fogh H, et al. Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial. Lancet 2000; 355: 963-6
53. Ammann R, HunzikerT, Braathen LR. Topical photodynamic therapy in verrucae: a pilot study. Dermatology 1995; 191: 346-7
54. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1990; 6: 143-8
55. Ross EV, Romero R, Kollias N, et al. Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment. Br J Dermatol 1997; 137: 736-42
56. Bissonnette R, Shapiro J, Zeng H, et al. Topical photodynamic therapy with 5-aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areata. Br J Dermatol 2000; 143: 1032-5
57. Silver H. Psoriasis vulgaris treated with hematoporphyrin. Arch Dermatol 1937; 36: 1118-9
58. Fritsch C, Lehmann P, Stahl W, et al. Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of δ-aminolaevulinc acid. Br J Cancer 1999; 79: 1603-8
59. Collins P, Robinson DJ, Stringer MR, et al. The variable response of plaque psoriasis after a single treatment with topical 5-aminolaevulinic acid photodynamic therapy. Br J Dermatol 1997; 137: 743-9
60. Robinson DJ, Collins P, Stringer MR, et al. Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. Acta Derm Venereol 1999; 79: 451-5
61. Stringer MR, Collins P, Robinson DJ, et al. The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy. J Invest Dermatol 1996; 107: 76-81
62. Bissonnette R, Tremblay J-F, Juzenas P, et al. Systemic photodynamic therapy with aminolevulinic acid induces apoptosis in lesional T lymphocytes of psoriatic plaques. J Invest Dermatol 2002; 119: 77-83